Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| Abbott's Bardoxolone in Phase III - Zacks.com |
|
|
|
Zacks.com The multinational, double-blind, placebo-controlled phase III study, BEACON (Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes: the Occurrence of renal eveNts), will be conducted with about 1600 patients across |
Professional dialysis recruitment

